Breast AI
Arterys
Product specifications |
Information source:
Vendor
Last updated: Nov. 2, 2022 |
General | |
---|---|
Product name | Breast AI |
Company | Arterys |
Subspeciality | Breast |
Modality | Mammography |
Disease targeted | Breast cancer |
Key-features | Lesion detection, segmentation, breast cancer risk estimation, automated breast density assessment |
Suggested use | Before: adapting worklist order, flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion After: diagnosis verification |
Data characteristics | |
Population | Women at any age |
Input | 2D full field digital mammogram, 3D digital tomosynthesis, 2D synthetic, 3D slabs |
Input format | DICOM |
Output | Density score assessment, lesion segmentation, risk score |
Output format | DICOM SC, SR, GSPS |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Stand-alone third party application |
Deployment | Cloud-based |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
, MDD/MDR
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 05-2022 |
Distribution channels | |
Countries present (clinical, non-research use) | 5 |
Paying clinical customers (institutes) | 10 |
Research/test users (institutes) | 10 |
Pricing | |
Pricing model | Pay-per-use |
Based on | Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |